TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT06384040 — Predictive Biomarker (PRD): DPP3 mRNA
Genes: DPP3
Study NCT05322876 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04988724 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05951504 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05951504 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT05196165 — Predictive Biomarker (PRD): GNE mRNA
Genes: GNE; GLCNE
Study NCT05918692 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT05029440 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04798001 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06503224 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT06503224 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06367725 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06243991 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT04906213 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT05846191 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05258175 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT05234151 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05091099 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05037591 — Predictive Biomarker (PRD): PGC mRNA
Genes: PGC
Study NCT06248632 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study NCT06248632 — Predictive Biomarker (PRD): PHEX mRNA
Genes: PHEX; PEX
Study NCT06501768 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06501768 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT04853511 — Predictive Biomarker (PRD): PLXNA2 mRNA
Genes: PLXNA2; KIAA0463; OCT; PLXN2; UNQ209/PRO235
Study NCT06395454 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT05087212 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT05087212 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT06554366 — Surrogate Endpoint (SUR): Bacterial count
Study NCT05488314 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT05965726 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06585332 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study NCT04953468 — Predictive Biomarker (PRD): ANXA2 mRNA
Genes: ANXA2; ANX2; ANX2L4; CAL1H; LPC2D
Study NCT06508125 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06585345 — Predictive Biomarker (PRD): CD7 mRNA
Genes: CD7
Study NCT05555121 — Predictive Biomarker (PRD): PIBF1 mRNA
Genes: PIBF1; C13orf24; PIBF
Study NCT05412654 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05513066 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06245330 — Predictive Biomarker (PRD): AKR1C3 mRNA
Genes: AKR1C3; DDH1; HSD17B5; KIAA0119; PGFS
Study NCT05295862 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04741984 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT04190550 — Predictive Biomarker (PRD): MDM2 mRNA
Genes: MDM2
Study NCT05512988 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT05512988 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT05415072 — Predictive Biomarker (PRD): GNAQ mRNA
Genes: GNAQ; GAQ
Study NCT04741646 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study NCT04741646 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study NCT06193889 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05145452 — Pharmacodynamic Biomarker (PDY): Survival motor neuron protein
Genes: SMN1; SMN; SMNT;; SMN2; SMNC
Study NCT06721598 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06720532 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06720532 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study NCT05295043 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT05295043 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05295043 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06037434 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT05963217 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06066554 — Predictive Biomarker (PRD): NLRP1 mRNA
Genes: NLRP1; CARD7; DEFCAP; KIAA0926; NAC; NALP1
Study NCT06066554 — Predictive Biomarker (PRD): NLRP3 mRNA
Genes: NLRP3; C1orf7; CIAS1; NALP3; PYPAF1
Study NCT06066554 — Safety Biomarker (SAF): Interleukin 18
Genes: IL18; IGIF; IL1F4
Study NCT05798949 — Predictive Biomarker (PRD): 14-3-3 protein sigma
Genes: SFN; HME1
Study NCT05769881 — Predictive Biomarker (PRD): CRH mRNA
Genes: CRH
Study NCT05769881 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study NCT06034470 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT06034470 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT05552950 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05659797 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study NCT05659797 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT05756946 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT05070598 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04682015 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05982626 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05606497 — Predictive Biomarker (PRD): FGR mRNA
Genes: FGR; SRC2
Study NCT05712616 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06323278 — Pharmacodynamic Biomarker (PDY): Lysosomal acid glucosylceramidase
Genes: GBA1; GBA; GC; GLUC
Study NCT06327451 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05156320 — Pharmacodynamic Biomarker (PDY): Survival motor neuron protein
Genes: SMN1; SMN; SMNT;; SMN2; SMNC
Study NCT06371118 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06199531 — Predictive Biomarker (PRD): NGLY1 mRNA
Genes: NGLY1; PNG1
Study NCT05299125 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05659095 — Predictive Biomarker (PRD): AGA mRNA
Genes: AGA
Study NCT05825846 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05341713 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05650437 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05596851 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05713721 — Predictive Biomarker (PRD): PINK1 mRNA
Genes: PINK1
Study NCT05713721 — Predictive Biomarker (PRD): GCH1 mRNA
Genes: GCH1; DYT5; GCH
Study NCT05407311 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05332821 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05170282 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT05698433 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05033886 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05876637 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05541822 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT06210022 — Predictive Biomarker (PRD): DSE mRNA
Genes: DSE; SART2
Study NCT05643872 — Predictive Biomarker (PRD): KRT6A mRNA
Genes: KRT6A; K6A; KRT6D
Study NCT05643872 — Predictive Biomarker (PRD): KRT6B mRNA
Genes: KRT6B; K6B; KRTL1
Study NCT05643872 — Predictive Biomarker (PRD): KRT6C mRNA
Genes: KRT6C; KRT6E
Study NCT05643872 — Predictive Biomarker (PRD): KRT16 mRNA
Genes: KRT16; KRT16A
Study NCT05847348 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05279911 — Predictive Biomarker (PRD): TNFRSF11B mRNA
Genes: TNFRSF11B; OCIF; OPG
Study NCT05981144 — Predictive Biomarker (PRD): NLRP3 mRNA
Genes: NLRP3; C1orf7; CIAS1; NALP3; PYPAF1
Study NCT05329662 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT05329662 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT06399575 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04871256 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT05076526 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06466122 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT05817188 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05611203 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04470674 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT05443932 — Surrogate Endpoint (SUR): Urinary oxalate
Study NCT05276544 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05971407 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04772352 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT00002028 — Predictive Biomarker (PRD): ARC mRNA
Genes: ARC; KIAA0278
Study NCT04812808 — Pharmacodynamic Biomarker (PDY): Signal transducer and activator of transcription 3
Genes: STAT3; APRF
Study NCT04812808 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT05064501 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05740618 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT05740618 — Predictive Biomarker (PRD): MCC mRNA
Genes: MCC
Study NCT06479291 — Predictive Biomarker (PRD): TPO mRNA
Genes: TPO
Study NCT04814771 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study NCT04958005 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04958005 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT04958005 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04958005 — Predictive Biomarker (PRD): IL6
Genes: IL-6; BSF2; HGF; HSF
Study NCT06300567 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT05891080 — Predictive Biomarker (PRD): BTLA mRNA
Genes: BTLA
Study NCT05651841 — Predictive Biomarker (PRD): SCGB1A1 mRNA
Genes: SCGB1A1; CC10; CCSP; UGB
Study NCT04867603 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05047510 — Predictive Biomarker (PRD): GPC3 mRNA
Genes: GPC3; OCI5
Study NCT04937660 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT04937660 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04931862 — Pharmacodynamic Biomarker (PDY): Guanine nucleotide exchange factor C9orf72
Genes: C9orf72; DENND9; DENNL72
Study NCT06291025 — Predictive Biomarker (PRD): ADAMTS13 mRNA
Genes: ADAMTS13; C9orf8; UNQ6102/PRO20085
Study NCT06291025 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT04791566 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05045001 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Interleukin 6 receptor alpha
Genes: IL6R
Study NCT05045001 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04931355 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT05040321 — Predictive Biomarker (PRD): IGF1 mRNA
Genes: IGF1; IBP1
Study NCT05040321 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05040321 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05230810 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT05230810 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05268939 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05999136 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05999136 — Surrogate Endpoint (SUR): Serum triglycerides
Study NCT05999136 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06346496 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT05874856 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06078761 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05131074 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05755685 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05752201 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06495164 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06495164 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06495164 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT06495164 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00006488 — Predictive Biomarker (PRD): GDNF mRNA
Genes: GDNF
Study NCT04883190 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05436951 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05685251 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05271253 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT05271253 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT05271253 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study NCT01970111 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT05901168 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05248022 — Pharmacodynamic Biomarker (PDY): Beta-secretase 1
Genes: BACE1; BACE; KIAA1149
Study NCT06338891 — Predictive Biomarker (PRD): MEFV mRNA
Genes: MEFV; MEF; TRIM20
Study NCT06338891 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT05780567 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05780567 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05849103 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05419700 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05419700 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05319522 — Predictive Biomarker (PRD): FNDC5 mRNA
Genes: FNDC5; FRCP2
Study NCT05319522 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06315673 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT05184140 — Predictive Biomarker (PRD): SLN mRNA
Genes: SLN
Study NCT04841902 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05053789 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05258890 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04528654 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05282017 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03539874 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT03539874 — Surrogate Endpoint (SUR): Sperm parameters
Study NCT06065033 — Predictive Biomarker (PRD): GLS mRNA
Genes: GLS; GLS1; KIAA0838
Study NCT06065033 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06242249 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT04798014 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT06183736 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT05520944 — Predictive Biomarker (PRD): CPM mRNA
Genes: CPM
Study NCT05039151 — Predictive Biomarker (PRD): ITGB1 mRNA
Genes: ITGB1; FNRB; MDF2; MSK12
Study NCT05589233 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04831203 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT04741061 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05630612 — Predictive Biomarker (PRD): EDNRA mRNA
Genes: EDNRA; ETA; ETRA
Study NCT05630612 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05821868 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT04980859 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT05742438 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06658639 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT06493695 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT06493695 — Safety Biomarker (SAF): BDNF
Study NCT05277701 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05416372 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05791266 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04634747 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT06095934 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05916391 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06370832 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study NCT05417061 — Predictive Biomarker (PRD): SIRT6 mRNA
Genes: SIRT6; SIR2L6
Study NCT05417061 — Predictive Biomarker (PRD): CASP8 mRNA
Genes: CASP8; MCH5
Study NCT05342259 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05914077 — Predictive Biomarker (PRD): GNAS mRNA
Genes: GNAS; GNAS1
Study NCT05914077 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT06469866 — Pharmacodynamic Biomarker (PDY): Transmembrane glycoprotein NMB
Genes: GPNMB; HGFIN; NMB; UNQ1725/PRO9925
Study NCT05810792 — Predictive Biomarker (PRD): CYBB mRNA
Genes: CYBB; NOX2
Study NCT05810792 — Predictive Biomarker (PRD): HDC mRNA
Genes: HDC
Study NCT05810792 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT05810792 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT05666258 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05666258 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05705986 — Predictive Biomarker (PRD): STING1 mRNA
Genes: STING1; ERIS; MITA; STING; TMEM173
Study NCT05249361 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT06024057 — Predictive Biomarker (PRD): RPE65 mRNA
Genes: RPE65
Study NCT06372184 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT04818281 — Surrogate Endpoint (SUR): Neutralizing antibody response
Study NCT04818281 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05947370 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT04803058 — Predictive Biomarker (PRD): CD2 mRNA
Genes: CD2; SRBC
Study NCT05555212 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05186597 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05767892 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05767892 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05624203 — Safety Biomarker (SAF): miR-140
Genes: MIR140
Study NCT06154954 — Predictive Biomarker (PRD): ECM1 mRNA
Genes: ECM1
Study NCT06154954 — Predictive Biomarker (PRD): LGALS3BP mRNA
Genes: LGALS3BP; M2BP
Study NCT05587920 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05587400 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT05982275 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT00000976 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05523661 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05523661 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT05230537 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT05631886 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT05503147 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study NCT04933942 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT05294172 — Predictive Biomarker (PRD): KL mRNA
Genes: KL
Study NCT04695925 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04695925 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT05819554 — Predictive Biomarker (PRD): SSTR5 mRNA
Genes: SSTR5
Study NCT05643768 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05195827 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05663177 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06290713 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT03970954 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03970954 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT06321965 — Pharmacodynamic Biomarker (PDY): Survival motor neuron protein
Genes: SMN1; SMN; SMNT;; SMN2; SMNC
Study NCT04963933 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05823623 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06507449 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study NCT05321368 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05949021 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05482711 — Predictive Biomarker (PRD): BMAL1 mRNA
Genes: BMAL1; ARNTL; BHLHE5; MOP3; PASD3
Study NCT05088785 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study NCT05088785 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT05441501 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06418412 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05876221 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT05876221 — Predictive Biomarker (PRD): ADAMTS13 mRNA
Genes: ADAMTS13; C9orf8; UNQ6102/PRO20085
Study NCT04676087 — Predictive Biomarker (PRD): CCR4 mRNA
Genes: CCR4; CMKBR4